Showing results (71-80 of 164) with videos related to

Sort By:
Pageof 17
International Journal of Cancer|September 7, 2023
Effects of adoptive T-cell immunotherapy on immune cell profiles and prognosis of patients with unresectable or recurrent cholangiocarcinomaAkihiko Kida, Eishiro Mizukoshi, Masaaki Kitahara, et al.
International Journal of Molecular Sciences|October 14, 2022
Alterations in Hepatocellular Carcinoma-Specific Immune Responses Following Hepatitis C Virus Elimination by Direct-Acting AntiviralsShihui Li, Eishiro Mizukoshi, Kazunori Kawaguchi, et al.
Cancer Immunology, Immunotherapy : CII|March 18, 2014
P53, hTERT, WT-1, and VEGFR2 are the most suitable targets for cancer vaccine therapy in HLA-A24 positive pancreatic adenocarcinomaTakeshi Terashima, Eishiro Mizukoshi, Kuniaki Arai, et al.
Cytotherapy|April 19, 2020
Identification of prognostic factors for γδT cell immunotherapy in patients with solid tumorRishu Takimoto, Tomoharu Miyashita, Eishiro Mizukoshi, et al.
Japanese Journal of Clinical Oncology|September 27, 2018
Treatment patterns and outcomes of unresectable pancreatic cancer patients in real-life practice: a region-wide analysisTakeshi Terashima, Tatsuya Yamashita, Akito Sakai, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 17, 2014
Blood neutrophil to lymphocyte ratio as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapyTakeshi Terashima, Tatsuya Yamashita, Noriho Iida, et al.
The American Journal of Gastroenterology|June 19, 2007
Impact of diabetes on recurrence of hepatocellular carcinoma after surgical treatment in patients with viral hepatitisTakuya Komura, Eishiro Mizukoshi, Yuki Kita, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 16, 2014
Characteristics of hepatic fatty acid compositions in patients with nonalcoholic steatohepatitisKazutoshi Yamada, Eishiro Mizukoshi, Hajime Sunagozaka, et al.
Pageof 17